Testing for iron deficiency and use of ferric carboxymaltose in patients with heart failure: need for implementation? data from the swedish heart failure registry

被引:0
|
作者
Becher, P. M. Peter Moritz [1 ]
Schrage, B. [1 ]
Benson, L. [2 ]
Dahlstrom, U. [3 ,4 ]
Lund, L. [2 ]
Savarese, G. [2 ]
机构
[1] Univ Heart & Vasc Ctr Hamburg, Hamburg, Germany
[2] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
[3] Linkoping Univ Hosp, Dept Cardiol, Linkoping, Sweden
[4] Dept Hlth, Linkoping, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:182 / 182
页数:1
相关论文
共 50 条
  • [41] “Real World” Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry
    Joanne Simpson
    L. Benson
    P. S. Jhund
    U. Dahlström
    J. J. V. McMurray
    L. H. Lund
    Cardiovascular Drugs and Therapy, 2019, 33 : 315 - 322
  • [42] HEALTH CARE COST FOR PATIENTS WITH CHRONIC HEART FAILURE AND IRON DEFICIENCY / ANEMIA BEFORE AND AFTER TREATMENT WITH FERRIC CARBOXYMALTOSE
    Kohls, M.
    Hardt, T.
    Barck, I
    Schultheiss, J.
    Heidler, T.
    Deiters, B.
    VALUE IN HEALTH, 2019, 22 : S554 - S554
  • [43] Heart failure in young adults: excerpts from the swedish heart failure registry
    Barasa, A.
    Alehagen, U.
    Edner, M.
    Dahlstrom, U.
    Schaufelberger, M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 1091 - 1091
  • [44] Use of heart failure evidence-based therapy across age strata: data from the Swedish Heart Failure Registry
    Stolfo, D.
    Lund, L. H.
    Orsini, N.
    Dahlstrom, U.
    Sinagra, G.
    Savarese, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 125 - 126
  • [45] Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function
    Macdougall, Iain C.
    Ponikowski, Piotr
    Stack, Austin G.
    Wheeler, David C.
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Goehring, Udo-Michael
    Kirwan, Bridget-Anne
    Kumpeson, Vasuki
    Metra, Marco
    Rosano, Giuseppe
    Ruschitzka, Frank
    van der Meer, Peter
    Waechter, Sandra
    Jankowska, Ewa A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (09): : 1124 - 1134
  • [46] Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure
    Spinner, Joseph A.
    Puri, Kriti
    Powers, Jacquelyn
    Dasari, Tejasvi
    Tunuguntla, Hari
    Choudhry, Swati
    Cabrera, Antonio G.
    Shah, Mona
    Dreyer, William J.
    Denfield, Susan W.
    Price, Jack F.
    CIRCULATION, 2019, 140
  • [47] Effectiveness and safety in the administration of carboxymaltose iron in outpatients with iron deficiency and heart failure
    Lozano-Edo, S.
    Arenas, P.
    Jover-Pastor, P.
    Ezzitouny, M.
    Sorolla, J.
    Calvo, M.
    Martinez-Sole, J.
    Guerrero, B.
    Sanchez, J. C.
    Navarrete, J.
    Donoso, V.
    Lopez-Vilella, R.
    Sanchez-Lazaro, I.
    Martinez-Dolz, L.
    Almenar, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 120 - 121
  • [48] BUDGET-IMPACT-ANALYSIS OF IRON TREATMENT USING INTRAVENOUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH CHRONIC HEART FAILURE AND IRON DEFICIENCY IN AUSTRIA
    Ressl, S.
    Walter, E.
    Bauer, M.
    VALUE IN HEALTH, 2015, 18 (07) : A384 - A384
  • [49] Definition of iron deficiency based on the gold standard of bone marrow iron staining and treatment effect of ferric carboxymaltose in heart failure patients
    Beverborg, N. Niels Grote
    Van der Meer, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 20 - 21
  • [50] Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry
    von Olshausen, Gesa
    Benson, Lina
    Dahlstrom, Ulf
    Lund, Lars H.
    Savarese, Gianluigi
    Braunschweig, Frieder
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1636 - 1646